Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line
Sign Up to like & getrecommendations! Published in 2019 at "Oncoimmunology"
DOI: 10.1080/2162402x.2019.1638210
Abstract: ABSTRACT Changes in the immune system induced by tyrosine kinase inhibitors (TKI) have been shown to positively correlate with therapy responses in chronic myeloid leukemia (CML). However, only a few longitudinal studies exist and no… read more here.
Keywords: patients treated; cml patients; diagnosed cml; imatinib ... See more keywords